COMMUNIQUÉS West-GlobeNewswire

MacroGenics Announces Participation in SVB Leerink Global Healthcare Conference
25/02/2019
ROCKVILLE, MD, Feb. 25, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Antares Pharma to Report Fourth Quarter and Full Year 2018 Financial and Operating Results
25/02/2019
EWING, N.J., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its fourth quarter and full year 2018 financial results and recent operating progress before the market [...]
R1 RCM to Present at the Cowen and Company 39th Annual Health Care Conference
25/02/2019
CHICAGO, Feb. 25, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced its management team will present [...]
PLx Pharma Inc. to Discuss 2018 Fourth Quarter and Full Year Financial Results on March 8, 2019 Conference Call
25/02/2019
HOUSTON, Feb. 25, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Vazalore™ 325 [...]
Amedisys Board of Directors Authorizes $100 million Stock Repurchase Program
25/02/2019
BATON ROUGE, La., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, today announced that its Board of Directors has authorized [...]
ReWalk Robotics Announces Closing of $4.37 Million Public Offering
25/02/2019
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Feb. 25, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced the closing and funding of its previously announced [...]
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2018 Financial Results on March 6, 2019
25/02/2019
Conference Call to Discuss Results on March 7, 2019 at 8:00 a.m. ET WARSAW, Indiana, Feb. 25, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively [...]
Recro Pharma Announces Publication of Phase III IV Meloxicam Clinical Safety and Opioid Use Data in the Journal Clinical Pharmacology in Drug Development
25/02/2019
Publication Highlights That IV Meloxicam Has a Safety Profile Similar to Placebo and Reduces Opioid Consumption MALVERN, Pa., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating [...]
Corcept Therapeutics Announces fourth quarter and full-year 2018 Audited Financial Results and provides corporate update
25/02/2019
MENLO PARK, Calif., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic [...]
Otonomy to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Corporate Update
25/02/2019
Webcast and Conference Call to be Held at 4:30 p.m. EST on March 4, 2019 SAN DIEGO, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative [...]
Alder BioPharmaceuticals® Reports Fourth Quarter and Full Year 2018 Financial and Operating Results
25/02/2019
- Completes eptinezumab’s Biologics License Application (BLA) submission - - Remains on track for eptinezumab’s commercial launch in Q1-2020 - - Strengthens leadership team with the appointments of Carlos Campoy as [...]
Medexus Pharmaceuticals Announces 512% Increase in Revenue to $14.4 Million for the Third Quarter of Fiscal 2019
25/02/2019
Generates $2.2 million of Adjusted EBITDA Medexus management to host conference call at 4:30 PM ET today MONTREAL, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “Company [...]
Stryker acquires Arrinex
25/02/2019
Kalamazoo, Michigan, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today it has completed the acquisition of Arrinex, Inc., a medical device company headquartered in Menlo Park, California, that has [...]
La Jolla Pharmaceutical Company to Release Fourth Quarter and Full Year 2018 Financial Results on March 4, 2019
25/02/2019
SAN DIEGO, Feb. 25, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
VistaGen Therapeutics Announces Proposed Public Offering of Common Stock
25/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 25, 2019 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central [...]
Immunomedics Reports Results For Period Ended December 31, 2018, Strengthens Board And Announces Senior Leadership Changes
25/02/2019
Preparation for Resubmission of BLA for Sacituzumab Govitecan Continuing Phase 2 Data in mTNBC Published in New England Journal of Medicine Oral Presentation of Updated Phase 1/2 Results with Sacituzumab Govitecan in [...]
Ultragenyx Announces Proposed Public Offering of Common Stock
25/02/2019
NOVATO, Calif., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, [...]
HealthPoint Plus, Inc. Announces Plan to File S-1 Registration Statement with the SEC to Register its Securities for Public Trading
25/02/2019
Danvers, MA, Feb. 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- HealthPoint Plus, Inc. www.healthpointplus.com announced today that it plans to file an S-1 registration statement upon completion of its final round of [...]
B. Braun Medical Acquires NxStage Medical, Inc.’s Streamline Bloodlines
25/02/2019
BETHLEHEM, Pa., Feb. 25, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. is pleased to announce the acquisition of the Medisystems ® Streamline ® Bloodlines business. The acquired bloodline systems will include the [...]

Pages